Two molecular pathways of human T cell adhesion: establishment of receptor-ligand relationship.
Shaw
S
S
Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland.
Shimizu
Y
Y
D000818:Animals; D000943:Antigens, Differentiation / Q000235:genetics / Q000502:physiology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000235:genetics / Q000502:physiology; D000954:Antigens, Surface / Q000235:genetics / Q000502:physiology; D018801:CD2 Antigens; D018968:CD58 Antigens; D002448:Cell Adhesion / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000502:physiology; D006801:Humans; D007157:Immunologic Surveillance; D018799:Intercellular Adhesion Molecule-1; D016169:Lymphocyte Function-Associated Antigen-1; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology; D011971:Receptors, Immunologic / Q000235:genetics / Q000502:physiology; D016028:Receptors, Leukocyte-Adhesion / Q000235:genetics / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology*
D000943:Antigens, Differentiation; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D018801:CD2 Antigens; D018968:CD58 Antigens; D015815:Cell Adhesion Molecules; D016169:Lymphocyte Function-Associated Antigen-1; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic; D016028:Receptors, Leukocyte-Adhesion; D018799:Intercellular Adhesion Molecule-1